Carcinoma of the Hypopharynx a Retrospective Analysis of the Treatment Results over a 25-Year Period

References

• UICC (International Union Against Cancer). TNM-Atlas. Illustrated guide to the classification of malignant tumors, B Spiessl, O Scheibe, G Wagner. Springer-Verlag, New York 1982; 22–6
   Google Scholar
• Holsti L R, Mäntylä M. Split-course versus continuous radiotherapy. Analysis of randomized trail from 1964 to 1967. Acta Oncol 1988; 27: 153–61
   PubMed Web of Science ®Google Scholar
• Holsti L R. Split-course radiotherapy of cancer. Acta Radiol Ther Phys Biol 1967; 6: 313–22
   PubMedGoogle Scholar
• Kaplan E L, Meier P. Non-parametric estimation from incomplete observation. J Am Stat Assoc 1958; 53: 457–81
   Web of Science ®Google Scholar
• Peto R, Pike M C, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patients: II Analyses and examples. Br J Cancer 1977; 35: 1–39
   PubMed Web of Science ®Google Scholar
• Mustakallio S. Über das Larynx- und Hypopharynxkarzinom, ihre Röntgenbehandlung und die Ergebnisse der therapie. Acta Radiol 1944; 25: 13–32
   Google Scholar
• Jacobsson F. Carcinoma of the hypopharynx. A clinical study of 322 cases, treated at Radiumhemmet from 1939–1947. Acta Radiol 1951; 35: 1–21
   PubMed Web of Science ®Google Scholar
• Kirchner J A. Pyriform sinus cancer: A clinical and Laboratory study. Ann Otol Rhinol Laryngol 1975; 84: 793–803
   PubMed Web of Science ®Google Scholar
• Ahmad K, Fayos J V. Role of radiation therapy in carcinoma of the hypopharynx. Acta Radiol Oncol 1984; 23: 21–6
   PubMed Web of Science ®Google Scholar
• Keane T J, Hawkins N V, Beale F A, et al. Carcinoma of the hypopharynx. Results of primary radical radiation therapy. Int J Radiat Oncol Biol Phys 1983; 9: 659–64
   PubMed Web of Science ®Google Scholar
• Briant T DR, Bryce D P, Smith T J. Carcinoma of the hypopharynx—a five-year follow-up. J Otolaryngol 1977; 6: 353–62
   PubMedGoogle Scholar
• Inoue T, Shigematsu Y, Sato T. Treatment of carcinoma of the hypopharynx. Cancer 1973; 31: 649–55
   PubMed Web of Science ®Google Scholar
• MacComb W S, Fletcher G H. Hypopharynx and cervical esophagus. Cancer of the head and neck, W S MacComb, G H Fletcher. Williams and Wilkins Co, Baltimore 1967; 213–40
   Google Scholar
• Arriagada R, Eschewege F. Combination of radiotherapy and surgery in the treatment of head and neck cancer. Cancer Treat Rev, Y Cachin, F Eschewege, 1975; 2: 177–92, Personal communication
   Google Scholar
• Wang C C. Role of radiotherapy. Head and neck oncology, H JG Bloom, I WF Hanham, H J Shaw. Raven Press, New York 1986; 103–8
   Google Scholar
• Million R, Cassisi N. Radical irradiation for carcinomas of the pyriform sinus. Laryngoscope 1981; 91: 439–50
   PubMed Web of Science ®Google Scholar
• Majiejewski B, Preuss-Bayer G, Trott K-R. The influence of the number of fractions and of overall treatment time on local control and late complication rate in squamous cell carcinoma of the larynx. Int J Radiat Oncol Biol Phys 1983; 9: 321–8
   PubMed Web of Science ®Google Scholar
• Maciejewski B, Withers R, Taylor J, Hliniak A. Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: tumor dose-response and repopulation. Int J Radiat Oncol Biol Phys 1989; 16: 831–43
   PubMed Web of Science ®Google Scholar
• Van der Bogaert W, van der Schueren E, Horiot J-C, et al. The feasibility of high-dose multiple daily fractionation and its combination with anoxic cell sensitizers in the treatment of head and neck cancer. Int J Radiat Oncol Biol Phys 1982; 8: 1649–55
   PubMed Web of Science ®Google Scholar
• Parsons J, Cassisi N, Million R. Results of twice-a-day irradiation of squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys 1984; 10: 2041–51
   PubMed Web of Science ®Google Scholar
• Kish J, Drelichmann A, Jacobs J. Clinical trial of cisplatin and 5-FU infusion as initial treatment for advanced squamous cell carcinoma of the head and neck. Cancer Treat Rep 1982; 66: 471–4
   PubMedGoogle Scholar
• Kish J, Ensley J, Jacobs J, et al. A randomized trial of cisplatin (CACP)+5-fluorouracil (5-FU) infusion and CACP+5-FU bolus for recurrent and advanced squamous cell carcinoma of the head and neck. Cancer 1985; 56: 2740–4
   PubMed Web of Science ®Google Scholar